What are the recommended surveillance and management strategies for a pregnant patient with a single uterine artery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Single Umbilical Artery in Pregnancy

For a pregnant patient with an isolated single umbilical artery (iSUA), perform a comprehensive anatomic survey with particular attention to cardiac and renal systems, then initiate third-trimester growth surveillance starting at 28-32 weeks with serial ultrasounds every 2-4 weeks, and begin weekly antenatal testing at 36 weeks of gestation.

Initial Diagnostic Approach

When a single umbilical artery (SUA) is detected on prenatal ultrasound:

Comprehensive Structural Assessment

  • Perform a detailed anatomic survey (CPT 76811) to evaluate for associated structural anomalies 1
  • Focus specifically on:
    • Cardiovascular system (most common associated anomaly) - if standard views are adequately visualized and normal, routine fetal echocardiography is not required 1
    • Genitourinary system (second most common) 2, 3
    • Central nervous system
    • Digestive system 3

Genetic Considerations

  • No additional aneuploidy screening is recommended for isolated SUA, regardless of whether previous screening was performed or declined 1
  • The risk of aneuploidy with isolated SUA is not increased 1
  • Offer invasive genetic testing only if structural anomalies are present - when SUA occurs with other abnormalities, aneuploidy risk ranges from 4-50% 1, 4

Surveillance Protocol for Isolated SUA

Growth Monitoring

Begin serial ultrasound surveillance for fetal growth at 28-32 weeks of gestation 4:

  • Perform growth scans every 2-4 weeks through the third trimester
  • Assess estimated fetal weight (EFW) and abdominal circumference
  • Monitor for small-for-gestational-age (SGA) - defined as EFW <10th percentile

Rationale: Research demonstrates that isolated SUA is associated with:

  • Increased risk of fetal growth restriction (FGR) 2, 5
  • Lower mean birth weight (approximately 3061g vs 3201g in controls) 3
  • Higher rates of SGA 2, 5

Antenatal Fetal Surveillance

Initiate weekly antenatal testing beginning at 36 0/7 weeks of gestation 1:

  • Non-stress testing (NST) or biophysical profile
  • Continue until delivery

Rationale: Isolated SUA carries increased risk of:

  • Stillbirth (OR 4.80) 1
  • Intrauterine fetal death, particularly in the second trimester 2
  • Fetal distress requiring cesarean delivery 2

Additional Monitoring

  • Assess amniotic fluid volume during growth scans
  • Monitor for oligohydramnios (increased risk with isolated SUA) 2

Delivery Planning

Timing of Delivery

  • For uncomplicated isolated SUA with normal growth: Deliver at 38-39 weeks 1
  • If FGR develops (EFW <10th percentile with normal umbilical artery Doppler): Consider delivery at 37-38 weeks
  • Earlier delivery may be indicated if:
    • Abnormal umbilical artery Doppler develops
    • Non-reassuring fetal testing
    • Severe FGR (EFW <3rd percentile)

Mode of Delivery

  • Vaginal delivery is appropriate for most cases of isolated SUA
  • Cesarean section indications remain standard obstetric criteria
  • Be prepared for increased likelihood of fetal distress during labor 2

Common Pitfalls to Avoid

  1. Don't miss associated anomalies: Up to 20% of SUA cases have additional structural abnormalities 3. The initial comprehensive survey is critical.

  2. Don't over-test for aneuploidy: Isolated SUA does not increase aneuploidy risk - avoid unnecessary invasive testing 1

  3. Don't skip third-trimester surveillance: Even "isolated" SUA carries real risks of FGR and stillbirth that require monitoring 1, 2, 5

  4. Don't delay delivery unnecessarily: While most outcomes are favorable, the increased stillbirth risk justifies delivery by 38-39 weeks rather than expectant management to 40-41 weeks 1

Expected Outcomes

With appropriate surveillance, most isolated SUA pregnancies have favorable outcomes 6:

  • No increased perinatal mortality when properly monitored
  • Approximately 66% will have normal growth
  • 34% may develop growth restriction requiring closer monitoring 2, 4
  • Neonates may have slightly lower Apgar scores and increased NICU admission rates 2

The key to optimizing outcomes is distinguishing truly isolated SUA from cases with associated anomalies, then implementing systematic third-trimester surveillance to detect and manage growth restriction and prevent stillbirth.

References

3
Research

Prenatal diagnosis of single umbilical artery and postpartum outcome.

European journal of obstetrics, gynecology, and reproductive biology, 2020

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What are the risks associated with rivaroxaban (Xarelto) therapy?
Which scoring system, RIPASA (RIPASA score) or Alvarado score, is more accurate for diagnosing acute appendicitis?
How should fetal wellbeing be monitored in a pregnancy with a single umbilical artery?
In a patient with pelvic inflammatory disease who cannot tolerate metronidazole, what alternative anaerobic agent and treatment regimen should be used?
How should pulmonary hypertension associated with an atrial septal defect (ASD) or Eisenmenger syndrome be treated?
What is the appropriate management for possible focal irritation or impingement of the right L5 nerve root in the subarticular recess at the L4/L5 level due to a disc bulge, with an incidental sacral Tarlov cyst?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.